Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |